Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
News Release
CEI Report Calls for Elimination of EPA’s Flawed Integrated Risk Information System
A new report released today by the Competitive Enterprise Institute (CEI) shows EPA’s Integrated Risk Information System (IRIS) has significant problems with methodology, relies on…
Study
EPA’s Flawed IRIS Program Is Far from Gold Standard
Environmental activists claim that the U.S. Environmental Protection Agency’s Integrated Risk Information System (IRIS) represents the gold standard for risk assessment.[i] In…
Blog
Last-Minute Delay in CVS-Aetna Deal Could Threaten Consumer Benefits
U.S. District Court Judge Richard Leon surprised many on Monday when he announced he may halt the integration of CVS pharmacy’s assets with the nation’s…
Washington Examiner
Safety Advocates Try To Hit The Brakes On Driverless Cars
Washington Examiner cited CEI’s Senior Fellow Marc Scribner on Congressional action for driverless vehicles. “I understand there are important things that need to…
Blog
Health and Human Services Secretary Should Halt Grants to UN Cancer Agency
Yesterday, Congress passed an appropriations bill that kept funding intact for the United Nations body known as the International Agency for Research on Cancer…
Blog
One Year Later, Federal Plan on Tobacco Harm Reduction Needs Improvement
The Food and Drug Administration has failed to approve a single reduced-harm nicotine product in the past year, despite unveiling a new “roadmap” in…